Phagelux
2013
FOUNDED
PRIVATE
STATUS
1-10
EMPLOYEES
Early Stage VC
LATEST DEAL TYPE
2
INVESTORS
Description
Developer of bacteriophages designed to provide alternatives to antibiotics for multiple fields. The company offers anti-bacterial products across multiple fields utilizing various phage and phage-based technologies, enabling users solve the bacterial problem and provide treatments to various diseases.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Delivery
Other Industries
Other Pharmaceuticals and Biotechnology
Biotechnology
Primary Office
- C-park Nanjing
- Shanghai, Jiangsu
- China
+86 139 0000 0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Phagelux’s full profile, request a free trial.
Phagelux Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC | 05-Feb-2016 | 0000 | Completed | Startup | ||
| 2. Early Stage VC (Series A) | 09-Jun-2015 | 0000 | 0000 | Completed | Startup | |
| 1. Early Stage VC | 06-Mar-2014 | Completed | Startup |
Phagelux Acquisitions (3)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000000 000000000 | 14-Oct-2015 | 000000000000000000 | Biotechnology | 0000000 0000 | |
| 0000000000 | 20-Jul-2015 | 000000000000000000 | Biotechnology | 0000 00000 | |
| Iveria Technologies (Novel Delivery Systems) | 23-Dec-2014 | Merger/Acquisition | Drug Delivery |
Phagelux Subsidiaries (1)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| 0000000000 | Biotechnology | Sandy, UT | 0000 |
Phagelux Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Fosun Pharma | Corporation | Minority | 000 0000 | 000000 0 | ||
| WuXi Healthcare Ventures | Corporate Venture Capital | Minority | 000 0000 | 000000 0 |
Phagelux Executive Team (4)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| William Wang | Chief Operating Officer | ||
| Joey Zhou | Director, Business Development | ||
| Rosemonde Mandeville Ph.D | CSO |
1 Former Executive
You’re viewing 3 of 4 executives. Get the full list »Phagelux Board Members (2)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Ge Li Ph.D | WuXi Healthcare Ventures | Board Member | 000 0000 | |
| Mark Engel | Phagelux | Board Member, Founder & Chief Executive Officer | 000 0000 |